Tag: NSCLC
-
Final Report: Utilization of Cancer Therapies for Advanced Non–Small Cell Lung Cancer With an Oncogenic Driver Mutation
Recent advancements in non–small cell lung cancer (NSCLC) treatment have introduced targeted therapies for tumours with specific oncogenic mutations, offering alternatives to standard chemotherapy. However, it is uncertain if patients with advanced NSCLC who have already undergone targeted therapies and chemotherapy can benefit from immune checkpoint inhibitors. This study examined current treatment patterns and explored…
CCRE Platform 